Skip to main content
Heidi Gray, MD, Obstetrics & Gynecology, Seattle, WA

Heidi Joy Gray MD

Gynecologic Oncology


Professor and Chief, Division of Gyn Oncology, Obstetrics & Gynecology, University of Washington School of Medicine

Join to view full profile
  • 1959 Ne Pacific StSeattle, WA 98195

  • Phone+1 206-598-8300

  • Fax+1 206-598-3590

Dr. Gray is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2001 - 2004
  • University of Washington
    University of WashingtonResidency, Obstetrics and Gynecology, 1997 - 2001
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1997

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1999 - 2027
  • PA State Medical License
    PA State Medical License 2001 - 2004
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • PARIS® Test Identified Effective Therapy for Patient with Terminal Ovarian Cancer
    PARIS® Test Identified Effective Therapy for Patient with Terminal Ovarian CancerSeptember 13th, 2021
  • SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian Cancer
    SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian CancerApril 13th, 2021
  • SGO 2019: Despite Missed Endpoint, JAVELIN Trial PD-L1 Subgroup Analysis Redeems
    SGO 2019: Despite Missed Endpoint, JAVELIN Trial PD-L1 Subgroup Analysis RedeemsMarch 19th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: